QPBE
RXRX icon

Quintet Private Bank (Europe)’s Recursion Pharmaceuticals RXRX Stock Holding History

Quintet Private Bank (Europe)’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.6K Buy
8,620
+5,000
+138% +$16.6K ﹤0.01% 152
2026
Q1 		$11.1K Hold
3,620
– – ﹤0.01% 173
2025
Q4 		$14.8K Buy
3,620
+1,620
+81% +$8.02K ﹤0.01% 167
2025
Q3 		$9.76K Buy
+2,000
New +$10.5K ﹤0.01% 180

Other funds holding RXRX

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Quintet Private Bank (Europe)'s RXRX Position: Q2 2026 in Review

Quintet Private Bank (Europe) increased its Recursion Pharmaceuticals (RXRX) stake by 138% in Q2 2026, buying an estimated $16.6K and bringing the position to 8,620 shares worth $31.6K. The position accounts for ﹤0.01% of the portfolio, ranked #152.

Quintet Private Bank (Europe) first reported a position in RXRX in Q3 2025 and has held it in 4 quarters since. 101 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Quintet Private Bank (Europe) held 8,620 shares of Recursion Pharmaceuticals worth $31.6K as of Q2 2026.
  • Quintet Private Bank (Europe) bought 5,000 Recursion Pharmaceuticals shares in Q2 2026, an estimated $16.6K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Quintet Private Bank (Europe)'s portfolio in Q2 2026, its #152 holding.
  • Quintet Private Bank (Europe) first reported a position in Recursion Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 101 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2026, filed 13 Jul 2026.